Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2415820
Affiliations:
18
Authors:
23
Institutions Authors Share
NewAmsterdam Pharma B.V., Netherlands
6.500000
0.28
Victorian Heart Hospital, Australia
3.000000
0.13
Mount Sinai Heart, United States of America (USA)
1.333333
0.06
Osaka Medical and Pharmaceutical University, Japan
1.000000
0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.04
Peking University First Hospital, PKUHSC, China
1.000000
0.04
University of Cambridge, United Kingdom (UK)
1.000000
0.04
Universitätsklinikum Leipzig, Germany
1.000000
0.04
Cleveland Clinic, United States of America (USA)
1.000000
0.04
University of Milan (UNIMI), Italy
1.000000
0.04
Medpace, United States of America (USA)
1.000000
0.04
Imperial College London (ICL), United Kingdom (UK)
1.000000
0.04
Medical University of Lodz (MUL), Poland
1.000000
0.04
University of Amsterdam (UvA), Netherlands
0.500000
0.02
Baylor College of Medicine (BCM), United States of America (USA)
0.500000
0.02
Texas Heart Institute (THI), United States of America (USA)
0.500000
0.02
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA)
0.333333
0.01
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
0.333333
0.01